Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-26-107413
Filing Date
2026-03-16
Accepted
2026-03-16 09:20:37
Documents
15

Document Format Files

Seq Description Document Type Size
1 S-3 d206837ds3.htm S-3 207522
2 EX-5.1 d206837dex51.htm EX-5.1 5722
3 EX-23.1 d206837dex231.htm EX-23.1 1979
4 EX-FILING FEES d206837dexfilingfees.htm   iXBRL EX-FILING FEES 18019
5 GRAPHIC g206837g0312114723173.jpg GRAPHIC 5439
6 GRAPHIC g206837g12p03.jpg GRAPHIC 58443
  Complete submission text file 0001193125-26-107413.txt   429129

Data Files

Seq Description Document Type Size
18 EXTRACTED XBRL INSTANCE DOCUMENT d206837dexfilingfees_htm.xml XML 4674
Mailing Address 12645 MEMORIAL DR., SUITE F1 #305 HOUSTON TX 77024
Business Address 12645 MEMORIAL DR., SUITE F1 #305 HOUSTON TX 77024 650.739.3939
Coya Therapeutics, Inc. (Filer) CIK: 0001835022 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-294315 | Film No.: 26754760
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)